Psychiatry and Clinical Psychopharmacology
Case Report

Neuroleptic malignant syndrome due to risperidone overdose in a child: a case report

1.

Department of Child Neurology, Istanbul Medeniyet University Goztepe Research and Training Hospital, Istanbul-Turkey

2.

Department of Child and Adolescent Psychiatry, Istanbul Medeniyet University Goztepe Research and Training Hospital, Istanbul-Turkey

Psychiatry and Clinical Psychopharmacology 2012; 22: 75-78
DOI: 10.5455/bcp.20111212084626
Read: 892 Downloads: 538 Published: 23 February 2021

Neuroleptic malignant syndrome is a rare, but potentially fatal idiosyncratic reaction to antipsychotic drugs that manifests itself consistently with hyperthermia, muscle rigidity, akinesia, altered mental state, autonomic instability, high creatine phosphokinase levels, and leukocytosis. We report here a case of risperidone-induced neuroleptic malignant syndrome in a 2.5-year-old boy who was given by mistake 2.5 mg risperidone instead of 0.25mg, as it is the youngest case reported in the literature.


Bir çocukta risperidon aşırı dozuna bağlı gelişen nöroleptik malign sendrom: Bir olgu sunumu

Nöroleptik malign sendrom, nadir görülen ancak ölümcül olabilen, antipsikotik ilaçlara karşı gelişen idiosenkrazik bir reaksiyondur. Bu sendrom hipertermi, kas rijiditesi, akinezi, şuur değişikliği, otonomik disfonksiyon, yüksek kreatinin kinaz seviyesi, lökositoz ile karakterizedir. Bu yazıda, risperidona bağlı nöroleptik malign sendrom gelişen, 2,5 yaşındaki erkek olgu, literatürdeki en küçük olgu olması nedeniyle sunulmuştur.

Files
EISSN 2475-0581